<DOC>
	<DOCNO>NCT02068482</DOCNO>
	<brief_summary>Diverticulosis colon frequent condition adult western country significant number patient experience clinical symptom even diverticulosis complicate diverticulitis . Both central mucosal immunity alter Uncomplicated Symptomatic Diverticular Disease ( USDD ) Rifaximin ameliorate clinical symptom normalize immunological abnormality . The Study Protocol verify modification immunological pattern induce reduce bacteria relate activation immunity Rifaximin treatment .</brief_summary>
	<brief_title>Immunohistology USDD Correlation Between Bacterial Flora Phlogosis</brief_title>
	<detailed_description />
	<mesh_term>Diverticulum</mesh_term>
	<mesh_term>Rifaximin</mesh_term>
	<criteria>male female age 18 radiologic endoscopic diagnosis diverticular disease locate sigma colon descendent Informed consent patient willing participate study colon diseases Inflammatory Bowel Diseases sign symptom inflammation consumption : antibiotic , antiinflammatory drug ( FANS 5ASA ) , prebiotics , Proton Pump Inhibitors , corticosteroid , fiber within three month pregnancy breast feed acute diverticulitis characterize : moderate/sever pain leave iliac fossa fever &gt; 38Â°C abdominal pain haematochezia leukocytosis ( 20 % normal range ) remote acute diverticulitis rifaximin hypersensitivity neoplastic disease immunodeficiency poor physical condition leaver deficiency ( Child C ) , kidney ( Creatinine &gt; 2,2 mg/dl ) , heart ( NYHA 34 ) major psychiatric illness drug abuse alcoholism participation clinical trial within 4 week patient unwillingness certificate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Uncomplicated</keyword>
	<keyword>Symptomatic</keyword>
</DOC>